US Stock MarketDetailed Quotes

Annovis Bio (ANVS)

Watchlist
  • 2.270
  • -0.010-0.44%
Close May 5 16:00 ET
  • 2.290
  • +0.020+0.88%
Post 20:01 ET
78.65MMarket Cap-1.62P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Annovis Bio (ANVS) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
85.11%19.53M
85.11%19.53M
20.97%15.29M
328.50%17.13M
608.84%22.24M
83.36%10.55M
83.36%10.55M
98.85%12.64M
-74.58%4M
-81.28%3.14M
-Cash and cash equivalents
85.11%19.53M
85.11%19.53M
20.97%15.29M
328.50%17.13M
608.84%22.24M
83.36%10.55M
83.36%10.55M
98.85%12.64M
-74.58%4M
-81.28%3.14M
Prepaid assets
-54.08%1.55M
-54.08%1.55M
10.30%1.9M
312.35%4.32M
-3.75%4.5M
-24.25%3.37M
-24.25%3.37M
-55.41%1.72M
-85.16%1.05M
-46.79%4.68M
Total current assets
51.39%21.08M
51.39%21.08M
19.69%17.19M
325.14%21.45M
242.20%26.74M
36.42%13.93M
36.42%13.93M
40.48%14.36M
-77.88%5.05M
-69.42%7.81M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
51.39%21.08M
51.39%21.08M
19.69%17.19M
325.14%21.45M
242.20%26.74M
36.42%13.93M
36.42%13.93M
40.48%14.36M
-77.88%5.05M
-69.42%7.81M
Liabilities
Current liabilities
Payables
12.34%2.59M
12.34%2.59M
-48.48%2.11M
-71.30%974.31K
-66.64%1.37M
78.37%2.31M
78.37%2.31M
112.80%4.1M
189.43%3.39M
-1.11%4.11M
-accounts payable
12.34%2.59M
12.34%2.59M
-48.48%2.11M
-71.30%974.31K
-66.64%1.37M
78.37%2.31M
78.37%2.31M
112.80%4.1M
189.43%3.39M
-1.11%4.11M
Current accrued expenses
-33.66%1.04M
-33.66%1.04M
25.53%1.62M
176.27%1.83M
48.61%1.13M
-47.26%1.58M
-47.26%1.58M
-21.15%1.29M
-26.45%662.68K
-39.35%763.18K
Current liabilities
-6.33%3.64M
-6.33%3.64M
-30.75%3.73M
-30.86%2.81M
-48.58%2.5M
-9.30%3.88M
-9.30%3.88M
51.24%5.39M
95.64%4.06M
-10.00%4.87M
Non current liabilities
Derivative product liabilities
-19.27%595K
-19.27%595K
-84.32%299K
-88.36%319K
-97.16%179K
-94.61%737K
-94.61%737K
--1.91M
--2.74M
--6.3M
Total non current liabilities
-19.27%595K
-19.27%595K
-84.32%299K
-88.36%319K
-97.16%179K
-94.61%737K
-94.61%737K
--1.91M
--2.74M
--6.3M
Total liabilities
-8.39%4.23M
-8.39%4.23M
-44.74%4.03M
-54.04%3.12M
-75.97%2.68M
-74.29%4.62M
-74.29%4.62M
104.71%7.3M
227.76%6.8M
106.37%11.17M
Shareholders'equity
Share capital
92.29%2.72K
92.29%2.72K
52.03%2.02K
66.21%1.95K
76.93%1.95K
34.41%1.41K
34.41%1.41K
47.23%1.33K
29.93%1.17K
33.94%1.1K
-common stock
92.29%2.72K
92.29%2.72K
52.03%2.02K
66.21%1.95K
76.93%1.95K
34.41%1.41K
34.41%1.41K
47.23%1.33K
29.93%1.17K
33.94%1.1K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-21.40%-163.7M
-21.40%-163.7M
-19.29%-153.87M
-26.01%-146.61M
-26.10%-140.39M
-22.30%-134.85M
-22.30%-134.85M
-46.50%-128.98M
-58.66%-116.35M
-74.51%-111.33M
Paid-in capital
25.25%180.55M
25.25%180.55M
22.77%167.02M
43.93%164.94M
52.30%164.44M
40.63%144.16M
40.63%144.16M
43.66%136.05M
21.82%114.59M
28.65%107.97M
Total stockholders'equity
81.05%16.85M
81.05%16.85M
86.25%13.16M
1,146.93%18.33M
817.16%24.05M
220.09%9.31M
220.09%9.31M
6.09%7.06M
-108.44%-1.75M
-116.66%-3.35M
Total equity
81.05%16.85M
81.05%16.85M
86.25%13.16M
1,146.93%18.33M
817.16%24.05M
220.09%9.31M
220.09%9.31M
6.09%7.06M
-108.44%-1.75M
-116.66%-3.35M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 85.11%19.53M85.11%19.53M20.97%15.29M328.50%17.13M608.84%22.24M83.36%10.55M83.36%10.55M98.85%12.64M-74.58%4M-81.28%3.14M
-Cash and cash equivalents 85.11%19.53M85.11%19.53M20.97%15.29M328.50%17.13M608.84%22.24M83.36%10.55M83.36%10.55M98.85%12.64M-74.58%4M-81.28%3.14M
Prepaid assets -54.08%1.55M-54.08%1.55M10.30%1.9M312.35%4.32M-3.75%4.5M-24.25%3.37M-24.25%3.37M-55.41%1.72M-85.16%1.05M-46.79%4.68M
Total current assets 51.39%21.08M51.39%21.08M19.69%17.19M325.14%21.45M242.20%26.74M36.42%13.93M36.42%13.93M40.48%14.36M-77.88%5.05M-69.42%7.81M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets 51.39%21.08M51.39%21.08M19.69%17.19M325.14%21.45M242.20%26.74M36.42%13.93M36.42%13.93M40.48%14.36M-77.88%5.05M-69.42%7.81M
Liabilities
Current liabilities
Payables 12.34%2.59M12.34%2.59M-48.48%2.11M-71.30%974.31K-66.64%1.37M78.37%2.31M78.37%2.31M112.80%4.1M189.43%3.39M-1.11%4.11M
-accounts payable 12.34%2.59M12.34%2.59M-48.48%2.11M-71.30%974.31K-66.64%1.37M78.37%2.31M78.37%2.31M112.80%4.1M189.43%3.39M-1.11%4.11M
Current accrued expenses -33.66%1.04M-33.66%1.04M25.53%1.62M176.27%1.83M48.61%1.13M-47.26%1.58M-47.26%1.58M-21.15%1.29M-26.45%662.68K-39.35%763.18K
Current liabilities -6.33%3.64M-6.33%3.64M-30.75%3.73M-30.86%2.81M-48.58%2.5M-9.30%3.88M-9.30%3.88M51.24%5.39M95.64%4.06M-10.00%4.87M
Non current liabilities
Derivative product liabilities -19.27%595K-19.27%595K-84.32%299K-88.36%319K-97.16%179K-94.61%737K-94.61%737K--1.91M--2.74M--6.3M
Total non current liabilities -19.27%595K-19.27%595K-84.32%299K-88.36%319K-97.16%179K-94.61%737K-94.61%737K--1.91M--2.74M--6.3M
Total liabilities -8.39%4.23M-8.39%4.23M-44.74%4.03M-54.04%3.12M-75.97%2.68M-74.29%4.62M-74.29%4.62M104.71%7.3M227.76%6.8M106.37%11.17M
Shareholders'equity
Share capital 92.29%2.72K92.29%2.72K52.03%2.02K66.21%1.95K76.93%1.95K34.41%1.41K34.41%1.41K47.23%1.33K29.93%1.17K33.94%1.1K
-common stock 92.29%2.72K92.29%2.72K52.03%2.02K66.21%1.95K76.93%1.95K34.41%1.41K34.41%1.41K47.23%1.33K29.93%1.17K33.94%1.1K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -21.40%-163.7M-21.40%-163.7M-19.29%-153.87M-26.01%-146.61M-26.10%-140.39M-22.30%-134.85M-22.30%-134.85M-46.50%-128.98M-58.66%-116.35M-74.51%-111.33M
Paid-in capital 25.25%180.55M25.25%180.55M22.77%167.02M43.93%164.94M52.30%164.44M40.63%144.16M40.63%144.16M43.66%136.05M21.82%114.59M28.65%107.97M
Total stockholders'equity 81.05%16.85M81.05%16.85M86.25%13.16M1,146.93%18.33M817.16%24.05M220.09%9.31M220.09%9.31M6.09%7.06M-108.44%-1.75M-116.66%-3.35M
Total equity 81.05%16.85M81.05%16.85M86.25%13.16M1,146.93%18.33M817.16%24.05M220.09%9.31M220.09%9.31M6.09%7.06M-108.44%-1.75M-116.66%-3.35M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +19.56%
Sample Name
Sample Code
 +14.20%
Sample Name
Sample Code
 +14.18%
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+10.58%
5
United Sts Brent Oil Fd Lp Unit
BNO
+8.71%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +21.01%
Sample Name
Sample Code
 +20.15%
Sample Name
Sample Code
 +14.82%
4
ASE Technology
ASX
+11.17%
5
Luckin Coffee
LKNCY
+10.14%
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump announced on the morning of August 5th, Eastern Time, that based on requests from countries such as Pakistan and signific Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -